QCI Interpret for Oncology
Benefits of integrating targeted next-generation sequencing (NGS) panels into molecular diagnostics of solid tumors
161 views
To address this challenge, a clinical research team led by Dr. Michela Bulfoni at the Istituto di Anatomia Patologica designed custom NGS panels, named “Glioma” and “Routine Diagnostics”, targeting single nucleotide variations, insertions/deletions, fusions, and copy number variations of tumor-associated essential genes.
In this webinar, attendees will:
- Understand the clinical utility of custom-designed NGS panels for accurate tumour diagnosis
- Learn about the design and application of these NGS panels
- Gain insights into the cost-effectiveness and high sensitivity of NGS panels in improving sample throughput
Category: QCI Interpret for Oncology, Sample to Insight
Related videos
QCI Interpret for Oncology
Real-World Applications of Clinical Metagenomic Sequencing in Cancer and Infectious Disease...
Clinical metagenomic next-generation sequencing (mNGS), the comprehensive...
QCI Interpret for Oncology
Clinician’s Roundtable: Interpreting genomic test results for precision oncology
You’re invited to attend the 2024 Clinician’s Roundtable, a virtual event...
QCI Interpret for Oncology
Comprehensive Molecular Tumor Analysis with Alacris Theranostics
Precision oncology approaches have made great strides harnessing individual...
QCI Interpret for Oncology
Agilent Alissa to QCI Interpret: How can your lab reduce the stress and complexity of...
In 2023, Agilent announced the discontinuation of their Alissa Interpret...